CBIH — Cannabis Bioscience International Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Market Cap
$8.31m
Enterprise Value
$17.45m
Revenue
$83.46m

Annual income statement for Cannabis Bioscience International Holdings, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

	2007 December 31st	2008 May 31st	C2009 May 31st	C2010 May 31st	2011 May 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	39.3	66.8	74	83.5
Cost of Revenue
Gross Profit	0	6.25	13	18	27.1
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	0.056	34	55.7	87.3	69.2
Operating Profit	-0.056	5.26	11.1	-13.3	14.3
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.056	5.08	11.1	-12.6	14.2
Provision for Income Taxes
Net Income After Taxes	-0.056	5.08	11.1	-12.6	11.2
Minority Interest
Net Income Before Extraordinary Items
Net Income	-0.056	4.8	10.5	-13.4	10.5
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.056	4.8	10.5	-13.4	10.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.18	4	7.4	-1.72	0.836
Dividends per Share